Different protocols of chemically induced hepatocarcinogenesis were applied to Wisfar rats under identical experimental conditions. The following conclusions may be drawn after an analytic comparison of these results. Various chemical carcinogens show different carcinogenic capacities. Diethylnitrosamine is more potent than N-nitrosomorpholine which i s more active than 2acetylaminofluorene. A short-term exposure to such carcinogens is sufficient to initiate but not necessarily to complete the carcinogenic process. It can be promoted to completion by either a noncarcinogenic promoter or a carcinogen.
INTRODUCTION
One of the main observations of the last decade concerning chemical carcinogenesis is the complexity of its biologic nature. When this process is initiated by exposure to a physical, chemical, or viral stimulus, malignant tumors appear only after a relatively long period of latency. It seems well-established that this period corresponds to the progressive transformation of the initially altered tissue (2, 8, 9, 27) .
One of the major contributions to the analysis of the complexity of the biologic process of chemical carcinogenesis is the distinction between initiation and promotion which was Presented at the Second International Symposium sponsored by the Universities of Sassari and Cagliari, Session Ilk "hletabolism of Chemical Carcinogens and Sequential Analysis." October 12-15. 1983 . Alghero. Italy. This Symposium section completes the scries of papers published in Volume 12.1984. introduced by Berenblum (2) . This distinction was based on the experimental observations that different chemicals can induce different phases of the skin carcinogenic process (3.4). However, although various authors have confirmed and extended Berenblum's observations, the specific biologic characteristics of these phases are still largely unknown. Thus, the distinction between initiation and promotion remains mainly operational. Moreover, the concept of initiationpromotion fails to explain some experimental evidences.
In the mouse skin model, for example, the chronic local administration of a carcinogen yields more malignant carcinoma than the initiation-promotion protocol which uses a subcarcinogenic dose of the same carcinogen followed by a noncarcinogenic promoter. Moreover, after a chronic. treatment only with an initiator [complete carcinogen), car-cinomas develop quicker than papillomas in the two-step procedure (19) . Furthermore, the hypothesis of Berenblum (2) that the number of tumors depends on the dose of the initiator and that the length of the latency period is controlled by the promoter has also been questioned. Some experimental data have indeed demonstrated that the increase of the dose of the initator shortens the period of latency without modifying the number of tumors and that two promoters may yield different numbers of malignant tumors (see Ref. 20 for review). Two-steps in the chemically initiated carcinogenic process have also been demonstrated for mammalian tissues other than the skin (9, 11, 13, 24) . During the last decade, the rat liver has received particular attention and various experimentaI protocols have been applied to study chemically induced hepatocarcinogenesis (9, 14, 15, 24, 26) .
The aim of the present report is to analyze the influence of complete carcinogenesis, of initiation, and of promotion relative to the length of the latency period between the first exposure to the carcinogen and the appearance of malignant tumors in rat liver. For this purpose, three protocols of hepatocarcinogenesis have been applied to the same rat strain (Wistar) under identical experimental conditions. The comparisons of the carcinogenic processes are based on a qualitative and quantitative kinetic evaluation of both the premalignant and the malignant lesions using biochemical and histochemical analysis of the activity of y-glutamyltransferase (GGT) (EC 2.3.2.2) as a marker of preneoplasia.
Applying a so-called "systemic analysis" (6, 8) , the results of the present study together with others reported in the literature will be discussed with the aim of reaching a more biologic description of the chemically initiated carcinogenic process. This so-called systemic analysis relies more on the analysis of the interactions between the various elements of a system or of a process rather than on the description of their nature.
METHODS

Chemicals, Animals, and Diets
Phenobarbital (PB), diethylnitrosamine (DEN), 2-acetylaminofluorene (AAF), and N- Fig. 1 ) for which young weanling rats of 22 days of age weighing d70 g were used. They were housed 4 per cage and received water and standard diet (A03, UAR, Villemoisson-sur-Orge, France) ad libitum. They were submitted to a constant illumination schedule (12 h of light-12 h of dark) in a hygrometry and temperature-controlled room. They were killed by decapitation and their liver was promptly dissected before fixation for histologic and histochemical evaluations. Samples for biochemical analysis were homogenized in a 0.25 M sucrose, 0.1 M buffer, pH 7.4. Biochemical determination of GGT was performed as described by Szasz (23) , using y-glutamylcarboxynitranilide (Boehringer) as substrate. PB (0.05%) and AAF (0.03%) were incorporated into the standard diet by UAR.
Histologic Analysis
Liver samples were fixed in neutral formol or in the Carnoy's solution for hematoxylineosin staining or freezed for histochemical analysis. Slides of 6-7 pm from each lobe were cut with a cryostat. The histochemical method of Rutenburg et a1 (18) was used to determine the activity of GGT. Quantification of positive area and statistical analysis of the results (variance analysis) were made by applying the computerized method developed in our laboratory by Cumps et a1 (5) .
Experimental Protocols
The experimental protocols used are schematically represented in Figure 1 .
Protocol I. Protocol of chronic intoxication as described by Teebor and Becker (26) . The rats received either 3 (Protocol Ia) or 4 (Protocol Ib) treatments. Each treatment consists of 3 weeks of a diet containing the carcinogen (AAF, 0.03%) followed by 1 week of normal diet.
Protocol II (Two-step Protocols). AAF plus PB (Protocol IIa) was used as described by Peraino et a1 (14) . However, in order to allow a better comparison between the experimental groups, this protocol was slightly modified so that the animals received the same dose of AAF (0.03% in diet for 3 weeks) as in Protocol I. After 1 week of normal diet, they received PB in the diet (0.05%) for 1 2 months. NNM plus PB (Protocol IIb) was used as described recently by Taper et al (25) . The animals received NNM continuously in their drinking water (0.025%) for 4 weeks. After 1 week of normal diet, they received PB in the diet (0.05%) until the end of the experiment. For comparison, a group of rats received only the NNM treatment without promotion (Pro-Protocol III (Triphasic Protocol). This protocol (Ma) has been described in detail previously (8, 12) . It consists strictly of a single i.p. injection of DEN (200 mg/kg) followed 2 weeks later by a selective procedure (modified Solt and Farber recipe (2211, and, followed 1 week later by chronic PB treatment. The selection procedure consisted of feeding the animals a diet containing 0.03% AAF for 2 weeks, and intragastric administration of a single necrogenic dose of CCI, (2 ml/kg diluted in corn oil) in the middle of this treatment.
In order to analyze the effect of PB, the first two phases of the triphasic protocol have been applied (Protocol IIIb).
RESULTS
Protocol I. In hepatocarcinogenesis by chronic intoxication with AAF, as previously reported by Teebor and Becker (26) , the 4th cycle of AAF feeding dramatically influences the hepatocarcinogenic process. In the 3-cycle protocol (Protocol Ia), 32 weeks after the beginning of the treatment, the liver paren-tocol IIC). chyma presents a normal morphologic aspect. GGT activity stains mainly in the periportal area and in a limited number of foci ( Fig.  2A ). In the 4-cycle protocol (Protocol Ib), the liver has a multinodular aspect. GGT activity is histochemically seen in many foci and nodules, but also in hepatocellular carcinomas ( Fig. 2B ). In that group (Protocol Ib), the GGTpositive lesions are 3 times more numerous than in the %cycle protocol. They occupy up to 50% of the surface area of the liver parenchyma examined (Table I) . Biochemical determinations of GGT activity in liver homogenates and in serum give values which correlate well with the quantitative histochemical results. No tumors were identified in the liver of the rats submitted to the 3-cycle protocol (Ia) 52 weeks after starting the treatment, whereas after the addition of a 4th cycle, 24 out of 29 animals (83%) developed hepatic tumors. Histopathologic evaluation of these tumors demonstrated their malignant characters. The majority were hepatocellular carcinomas since 21 rats (72%) had one or more well-characterized hepatocarcinomas. Moreover, 3 rats (10%) also had cholangiocarcinomas and one had both of these malignant tumors.
Protocol II. Hepatocarcinogenesis by initiation plus promotion (Protocol 11) includes two subsets of protocols.
Protocol IIa (AAF plus PB). Except for the concentration of AAF in the diet which was increased up to 0.03% and the difference in rat strain (Wistar instead of Sprague-Dawley), the protocol used in this experiment was essentially the same as that described by Peraino et a1 (14) . In order to follow the kinetics of the evolution of the benign and malignant liver lesions, groups of rats were killed at 12- week-intervals from 24 to 76 weeks after starting the experiment. The macroscopic observations, in this biphasic protocol revealed that the livers of rats were not multinodular, a finding often observed after chronic intoxication (see Protocol Ib in Fig. 2B and Table  1 ).
In all groups, approximately 20% of the rats had a tumor of the Zymbal gland. This type of tumor was also observed in rats submitted to chronic intoxication (Protocol I) and is frequently associated with AAF treatment (10) . However, in our experimental conditions, no correlation was observed between the presence of such a tumor and any particular hepatic lesion. Only a few tumors were observed in other nonhepatic tissues, such as the mammary gland.
The quantitative analysis of the GGT-positive lesions revealed the presence of only small foci starting along the perinodular zone. Both the number and percentage of liver surface area occupied were small and remained relatively constant during the experiment ( Table 11 ). A good correlation was observed between the histochemical evaluation and the biochemical assay of GGT activity both in liver homogenates and in sera. Even though both the size and the number of GGTpositive neoplastic lesions were and remained small during PB treatment, an increasing number of rats had hepatic tumors. However, if the relative number of rats bearing benign lesions increased progressively starting from the early beginning of promotion and reaching 90% at the end, the proportion of animals with malignant tumors increased linearily starting at week 36 and reached 65% 40 weeks later ( Fig. 3 ).
Protocol IIb (NNM Plus PB). The only difference between Protocols IIb and IIa was the replacement of AAF by NNM which was given continuously during 4 weeks as a 0.025% solution in drinking water in place of AAF feeding. Such a modification had a marked influence on the hepatocarcinogenic process. As early as 36 weeks after starting (-) or malignant (---) tumors during the biphasic protocol using AAF and PB.
FIG. 3-Evolution of the number of animals bearing benign
The numbers in parentheses indicate the number of animals at time of death.
the experiment, 80% of the rats developed hepatic malignant tumors (Table 111 ). There was an average of more than one hepatocarcinoma per rat and the livers were multinodular as observed after chronic intoxication (see Protocol Ib). Such differences are evidently due to the higher potency of NNM as compared to AAF, since even in the absence of any promoting treatment (Protocol IIc), nearly 50% of the animals also had more than one malignant liver tumor and numerous hyperplastic nodules.
Protocol IIIa Triphasic: Hepatocarcinogenesis by Initiation-Selection Plus Promotion. Initiation-selection used in Protocols IIIa and IIIb were essentially equivalent to that described by Solt and Farber (22) . However, Wistar rats were used instead of Fisher 344, the concentration of AAF on diet was increased up to 0.03%, and CCl, was used as mitogenic stimulus (12) . We have reported previously, that a chronic PB treatment after initiation-selection (Protocol IIIa) dramatically influences the premalignant phase of hepatocarcinogenesis. In the liver of rats submitted to the Solt and Farber protocol (Protocol IIIb), most of the GGT-positive foci which appear after initiation-selection remodel and disappear leaving few lesions which subsequently progress. The addition of chronic PB treatment as in the triphasic protocol (IIIa) prevents such a remodeling. Further, the reIative proportion of the liver parenchyma which is occupied by such phenotypically altered lesions is high, reaching in some cases, up to 60-70% within a few days (Table IV) . Twelve weeks after starting the initiation by a single dose of DEN, the liver of most of the rats showed a multinodular aspect similar to that seen after the 4-cycle chronic treatment (Protocol Ib). Such an effect of PB is also seen with regard to malignant tumors (Table IV) . As early as 17 weeks after initiation, 1 out of 9 rats already had a malignant tumor, whereas after 33 weeks, 9 out of 10 animals developed cancers. ' Details of protocols in the tests.
Expressed as number of rats bearing malignant tumor.
Histologically, most of the tumors were welldifferentiated hepatocellular carcinomas and one glandular carcinoma. In the livers of rats developing malignant tumors, nodules seemed to be less numerous and more heterogenous in their phenotypic alterations. Some cholangiomas were also seen in few animals. As in other protocols, the histochemical quantification of GGT-positive lesions correlated with the biochemical determination both in liver homogenate and in serum.
DISCUSSION
The results of the experiments reported here essentially confirm those previously reported for each experimental model (14, 22, 26) . However, they were substantially expanded by detailed histologic analysis of the observed lesions. The original results of the present report include the comparative analysis of different protocols for hepatocarcinogenicity applied to the same strain of rat kept under the same experimental conditions. If some results differ slightly, either qualitatively or quantitatively from those obtained in other laboratories, these differences could be due to either the rat strain sensitiveness or to the doses of chemicals used. These differences have been described in the text. A systemic comparison of the results obtained using the various protocols together with the conclusions of analogous experiments reported elsewhere (1, 28) allows us to draw the following conclusions (Table V) .
-Four consecutive cycles of feeding a diet containing 0.03% AAF give the rat a cumulative dose of carcinogen sufficient to complete malignant transformation in most animals within 13 months.
-Three consecutive cycles of the same treatment are sufficient to induce the appearance of a large number of nodules, but not to cause the appearance of malignant AAF (3 cycles) 5 
12
' See text for details of treatments.
tumors in the same time period. Further, the nodules seem to remodel progressively. -One cycle of AAF feeding is able to initiate the hepatocarcinogenic process which needs to be promoted by further chronic treatment. This is evidenced by the effect of feeding rats a diet containing PB. In this case, hepatocarcinogenesis could follow a different pathway since only a few benign lesions develop. Otherwise, the latency period is longer than the 4-cycle protocol. The efficiency of the carcinogenic process is lower since only 65% of rats bear tumors after the biphasic protocol (IIa), as compared to 80% in the chronic feeding protocol (Ib).
Before drawing further comparisons, we should look at the conclusions of Williams et a1 (28) . They applied two analogous protocols showing that PB given as a promoter after 3 cycles of AAF feeding suppresses the remodeling of the nodules and induces the appearance of few malignant tumors within 24 weeks; and that DEN given chronically after 3 cycles of AAF feeding acts like PB but with a higher efficiency in promoting malignant transformation. TOXICOLOGIC PATHOLOGY Thus, it seems that sufficiently chronic feeding of rats with a carcinogen (AAF) or with two different carcinogens (AAF + DEN) is more efficient in the development of malignant tumors than a shorter subcarcinogenic feeding (1 or 3 cycles of AAF) followed by a promoter (PB) treatment. Such conclusions have also been drawn from experiments related to skin carcinogenesis (19, 20) .
The second set of conclusions concerns the comparison of the effects of two carcinogens, AAF and NNM.
-NNM appears to be a more potent carcinogen than AAF since 4 weeks of NNM feeding induce malignant tumors within 36 weeks, an effect which AAF does not produce even after 76 weeks at a 2-3 times higher cumulative dose.
-The association NNM + PB is more efficient than any combination of AAF (1 or 3 cycles) + PB. After NNM, chronic PB treatment reduces the latency period for the appearance of malignant tumors, and increases the incidence of malignant tumors as compared to the effects after AAF feeding.
We recently reported (16) that DEN appears to be more potent than NNM in terms of initiating capacity. Even though the experimental conditions were different, the results of the experiments reported by Barbason et a1 (I) seem to lead to the same conclusions. This report supports the fact that a chronic exposure to a carcinogen (DEN) is always more efficient both in frequency and rapidity for malignant transformation than a shorter exposure by the same carcinogen followed by chronic PB feeding. Thus, the nature of the soTcalled initiator does not only influence the incidence of cancer (number of animals bearing tumors), but also influences the latency period. In terms of each carcinogen, the cumulative dose given to the rat influences not only the incidence but also the onset of the carcinogenic process (1) . Using the most potent of these three carcinogens (AAF, DEN, NNM), Solt and Farber (22) reported that it is possible to reduce the exposure of DEN to a single dose, but always in association with a short chronic treatment with a weaker hepatocarcinogen (AAF) which stimulates cell proliferation. Neither a single dose of DEN nor the AAF treatment associated with the mitogenic stimulus is sufficient to induce malignant transformation by itself. According to their hypothesis, AAF is acting through a selective toxicity toward the noninitiated cells giving the initiated cells an advantage for proliferation. Such an initiating-selecting protocol (Protocol IIIb) induces the appearance first of the neoplastic stage and later the malignant stages in most treated rats within 40-60 weeks. The Solt and Farber protocol leads essentially to the same results as the chronic AAF intoxication protocol (Ib). It remains less efficient than either chronic DEN feeding (1) or DEN or NNM + PB treatment.
Thus, initiation and selection seems necessary and sufficient to induce a carcinogenic process which can be accelerated by further treatment either with a carcinogen or with a noncarcinogen so-called promoter (12, 17) .
The results of the experiments using the triphasic protocol (IIIa) support this conclusion. In terms of neoplastic stages (as evidenced by GGT-positive lesions), cancer incidence, or latency period, such protocol appears to be the most potent of all tested. It is as potent as the strongest chronic DEN protocols applied by Barbason et a1 (1) . The triphasic protocol has the advantage of clear separation of different stimuli (initiating-selecting-promoting) for each phase, thus allowing a better analysis and a modulation of their roles. Using such a protocol we have already reported a dose-effect relationship with regard to the dose of the initiator (16), compared the effects of different promoters (16) , and demonstrated that a surgical treatment like portocaval anastomosis yields results similar to PB promotion in terms of malignancy (17) . The following seem to us to be general conclusions of this systemic analysis.
-Various chemical carcinogens show different hepatocarcinogenic potential with regard to the compounds used here: DEN > NNM > AAF appears to be the order of potency.
-A short exposure to these carcinogens is sufficient to initiate, but not necessarily to complete, the carcinogenic process which can thus be promoted to completion by either a noncarcinogenic promoter or by a carcinogen.
-Chronic exposure to a carcinogen is always more potent than exposure to a lower cumulative dose of the same carcinogen followed by treatment with a promoter. Four cycles of AAF and 3 cycles of AAF and 1 cycle of DEN are more carcinogenic than 3 cycles of AAF and PB which in turn is more carcinogenic than 1 cycle of AAF plus PB.
-The so-called initiation of the carcinogenic process is more than just a single event;
it implies an initiation strict0 sensu, but also a selective phase which corresponds to events necessary and sufficient to induce the complete carcinogenic process.
-The complete carcinogenic process can be accelerated and/or amplified by exposure to either carcinogenic or noncarcinogenic promoters.
-From initiation-selection to malignant transformation, the hepatocarcinogenic process may follow various pathways. With regard to neoplastic stages, these do not always quantitatively correlate with malignant transformation. The severity of the neoplastic lesions may be directly related to the dose of the initiator at early stages, but not related to the efficiency of promoting treatment (16) .
Taken together, these observations indicate that the distinction between initiation and promotion is really only operational and does not define clearly the nature of the different biologic phenomena resulting from the action of initiating and promoting agents. The selection process in the liver can be considered as a true phase of the biologic process of malignant transformation that could be at least triphasic. A more systemic definition of these phases and of their biologic aspects in carcinogenesis has been proposed recently (6, 7).
